|
FOR IMMEDIATE RELEASE
P07-76
May 1, 2007
|
Media
Inquiries:
Catherine McDermott, 301-827-6242
Consumer Inquiries:
888-INFO-FDA
|
The Food and Drug Administration (FDA) is cautioning U.S. consumers about
dangers associated with buying prescription drugs over the Internet. This
alert is being issued based on information the agency received showing that
24 apparently related Web sites may be involved in the distribution of counterfeit
prescription drugs.
On three occasions during recent months, FDA received information that counterfeit
versions of Xenical 120 mg capsules, a drug manufactured by Hoffmann-La Roche
Inc. (Roche), were obtained by three consumers from two different Web sites.
Xenical is an FDA-approved drug used to help obese individuals who meet certain
weight and height requirements lose weight and maintain weight loss.
None of the capsules ordered off the Web sites contained orlistat, the active
ingredient in authentic Xenical. In fact, laboratory analysis conducted
by Roche and submitted to the FDA confirmed that one capsule contained sibutramine,
which is the active ingredient in Meridia, an FDA-approved prescription drug
manufactured by Abbott Laboratories.
While this product is also used to help people lose weight and maintain that
loss, it should not be used in certain patient populations and therefore is
not a substitute for other weight loss products. In addition the drug
interactions profile is different between Xenical and sibutramine, as is the
dosing frequency; sibutramine is administered once daily while Xenical is dosed
three times a day.
Other samples of drug product obtained from two of the Internet orders were
composed of only talc and starch. According to Roche, these two samples displayed
a valid Roche lot number of B2306 and were labeled with an expiration date
of April 2007. The correct expiration date for this lot number is actually
March 2005. Pictures of the counterfeit Xenical capsules provided by
Roche can be viewed at http://www.fda.gov/bbs/topics/news/photos/xenical.html.
Roche identified the two Web sites involved in this incident as brandpills.com
and pillspharm.com. Further investigation by FDA disclosed that
these Web sites are two of 24 Web sites that appear on the pharmacycall365.com
home page under the "Our Websites" heading. Four of these
Web sites previously have been identified by FDA's Office of Criminal Investigations
as being associated with the distribution of counterfeit Tamiflu and counterfeit
Cialis.
At this point, it appears that these Web sites are operated from outside of
the United States. Consumers should be wary, if there is no way to contact
the Web site pharmacy by phone, if prices are dramatically lower than the competition,
or if no prescription from your doctor is required. As a result,
FDA strongly cautions consumers about purchasing drugs from any of these Web
sites which may be involved in the distribution of counterfeit drugs and reiterates
previous public warnings about buying prescription drugs online. Consumers
are urged to review the FDA Web page at www.fda.gov/buyonline/ for
additional information prior to making purchases of prescription drugs over
the Internet.
The 24 Web sites appear on pharmacycall365.com.
AllPills.net
Pharmacy-4U.net
DirectMedsMall.com
Brandpills.com
Emediline.com
RX-ed.com
RXePharm.com
Pharmacea.org
PillsPharm.com
MensHealthDrugs.net
BigXplus.net
MediClub.md
InterTab.de
Pillenpharm.com
Bigger-X.com
PillsLand.com
EZMEDZ.com
UnitedMedicals.com
Best-Medz.com
USAPillsrx.net
USAMedz.com
BluePills-Rx.com
Genericpharmacy.us
I-Kusuri.jp
####
From the FDA
May 1, 2007
http://www.fda.gov/bbs/topics/NEWS/2007/NEW01623.html